Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07096544 · ClinicalTrials.gov registry record · NA
CALM Study: Cardiomems Assisted Lvad Management
A NA study, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07096544 is a NA study that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 40 participants.
The verdict
NCT07096544, a NA study, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the control patients receiving standard of care treatment.
Interventions
- DEVICE CardioMEMS Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-05-08 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07096544
The ClinicalTrials.gov registry entry for NCT07096544 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CardioMEMS Device is the first listed.
NCT07096544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07096544 about?
NCT07096544 is a clinical study titled "CALM Study: Cardiomems Assisted Lvad Management". This prospective, open label, randomized, single-center pilot clinical trial will determine if the rate of heart failure related (HFR) hospitalizations is less in LVAD patients whose PAP is monitored with the CardioMEMS device vs the control patients receiving standard of care treatment.
What is the current status of trial NCT07096544?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-05-08. Estimated completion is 2027-09-01.
What interventions are being tested in trial NCT07096544?
The interventions under investigation include: CardioMEMS Device (DEVICE).
Who is sponsoring clinical trial NCT07096544?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.